Digital Health Assistant & Symptom Checker | Symptoma
0%
Restart

Are you sure you want to clear all symptoms and restart the conversation?

About COVID-19 Jobs Press Scholarship Terms Privacy Imprint Medical Device Language
Languages
Suggested Languages
English en
Other languages 0
2.1
Inclusion Body Myositis
Inclusion Body Myositides

Inclusion body myositis (IBM) is an inflammatory muscle disorder, characterized by progressive muscle weakness and wasting.

Presentation

Since the disease has a gradual onset and a slow progression, the signs and symptoms are not alarming and can only be noted after a while.

The disease includes degenerative changes of the muscle tissue, primarily either the wrists or the thighs. The symptoms can be noticed by the patients when they complain of loss of grip either while walking, wearing footwear, lifting their feet or in the case of the upper extremity when holding a bag or lifting a suitcase and gripping objects which may lead to many accidental drops or slipping and falling.

70% of the patients usually experience similar symptoms involving the use of extremities. 30 to 35% patients have involvement of other muscle tissues like that of the oesophagus that leads to difficulty in swallowing. Specifically in inclusion body myositis, the other muscle tissues like cardiac muscle or skin and lungs are generally not involved unlike other myopathies.

Notable Signs:

  • History of frequent falls
  • Difficulty in getting up from a chair or from standing after lying down
  • Clumsiness while walking, tripping often or loss of footing
  • Awkwardness with the upper extremities – dropping of things from hands due to a weak grip
  • Difficulty while swallowing

Symptoms that can be observed:

  • Visible shrinking of the quadriceps due to atrophy
  • Muscle power grade weakened in the forearm
  • Muscle power grade decreased below the knees
  • Muscle power and contraction difficult around the MCP joints and weaker grip on pinching and squeezing with fingers noted during examination

Entire Body System

  • Weakness

    This is in contrast to the proximal predominant pattern of weakness seen in DM, PM, and NM. Similarly, knee extension weakness out of proportion to hip flexion weakness is supportive of IBM. [ncbi.nlm.nih.gov]

    All 5 patients with leg weakness at onset had weakness of the quadriceps. [jamanetwork.com]

  • Inflammation

    Muscle biopsy, often utilized in the diagnosis, demonstrates a chronic myopathy with mixed pathologies harbouring intramyofiber protein inclusions and endomysial inflammation. [ncbi.nlm.nih.gov]

    […] of extensor carpi ulnaris muscle tendon Inflammation of extensor indicis muscle tendon Inflammation of extensor pollicis longus muscle tendon Inflammation of flexor carpi radialis muscle tendon Inflammation of flexor carpi ulnaris muscle tendon Intermuscular [icd9data.com]

  • Falling

    Patients were reported to have experienced dysphagia (60.2%) and injurious falls (44.3%) during their disease. [ncbi.nlm.nih.gov]

    Some of the first signs of inclusion body myositis are falling, difficulty getting up from a chair, and weakened grip. [myositis.org]

    Instead, management of the disease focuses on fall prevention and supplemental exercise therapy. [phoenixstemcelltreatmentcenter.com]

    Many patients say they have balance problems and fall easily, as the muscles cannot compensate for an off-balanced posture. [en.wikipedia.org]

  • Asymptomatic

    He remained asymptomatic for the ensuing 2.5 years. Asymptomatic hyperCKemia should be investigated and followed closely for definitive diagnosis and possible treatable causes. [ncbi.nlm.nih.gov]

    Hereditary inclusion-body myopathy (h-IBM) with quadriceps sparing: epidemiology and genetics 12: Familial autosomal-recessive inclusion-body myositis with asymptomatic leukoencephalopathy 13: Welander distal myopathy - clinical, pathophysiological, and [cambridge.org]

Respiratoric

  • Dyspnea

    Dyspnea in the elderly can be due to a wide array of pathologies. We discuss a case of an elderly gentleman with an extensive cardiovascular history presenting with acute worsening of chronic dyspnea. [ncbi.nlm.nih.gov]

    She presented with weakness and walking difficulty and reported dyspnea on exertion. CPK was increasing as well (271 IU/l). SCIg was thus initiated on November 25, 2011, as IVIg was only slightly beneficial. [karger.com]

Gastrointestinal

  • Vomiting

    This test can be used to determine the cause of painful swallowing, difficulty with swallowing, abdominal pain, bloodstained vomit, or unexplained weight loss. [understandingmyositis.org]

Musculoskeletal

  • Myopathy

    For further details on DM, PM, and NM, the reader is referred to the idiopathic inflammatory myopathies chapter. [pesquisa.bvsalud.org]

    G71.3 Mitochondrial myopathy, not elsewhere classified G71.8 Other primary disorders of muscles G71.9 Primary disorder of muscle, unspecified G72 Other and unspecified myopathies G72.0 Drug-induced myopathy G72.1 Alcoholic myopathy G72.2 Myopathy due [icd10data.com]

    Inclusion body myositis and myopathies. Ann Neurol. 1995; 38 (5):705–713. [ PubMed ] 16. Amato AA, Barohn RJ. Idiopathic inflammatory myopathies. Neurol Clin. 1997; 15 (3):615–648. [ PubMed ] 17. [ncbi.nlm.nih.gov]

    A new autosomal dominant myopathy (OMIM 605637 inclusion body myopathy 3) associated with a missense mutation in the myosin-heavy chain (MyHC) IIa gene has been described recently. [ageing.oxfordjournals.org]

  • Muscle Weakness

    Examination of the flexor digitorum profundus muscle is important for the early and proper diagnosis of sIBM, even if a patient only presents with isolated finger flexor muscle weakness. [ncbi.nlm.nih.gov]

    […] accompanied by muscle weakness. [ninds.nih.gov]

  • Myalgia

    The unexpected appearance of myalgia during the course of painless inclusion body myositis must arouse the suspicion of an association of another inflammatory muscle disease, macrophagic myofasciitis. [ncbi.nlm.nih.gov]

    Case 1 A 63-year-old woman presented with a 4-year history of myalgia related to statin therapy. Myalgia persisted more than 1 year after statin discontinuation in 2010. [karger.com]

    Myalgia and muscle tenderness may occur in a small number of patients, usually early in the disease, and particularly in DM associated with connective tissue disorders. [accessmedicine.mhmedical.com]

    […] a greater extent than the dominant side The most common complaint is quadriceps weakness Finger flexor and ankle dorsiflexion weakness can be noted clinically Dysphagia is a common symptom ( J Neurol 2005;252:1448 ) Generally, patients do not report myalgias [pathologyoutlines.com]

  • Proximal Muscle Weakness

    We report a 17-year-old girl with an unusual neuromuscular disorder characterised by slowly progressive proximal muscle weakness whose muscle biopsy showed multiple ring fibres and numerous rimmed vacuoles as well as intracytoplasmic and intranuclear [ncbi.nlm.nih.gov]

    weakness Common Causes of Proximal Muscle Weakness With Elevated CK • Inflammatory myositis • Noninflammatory myopathies • • • • Hypothyroidism Hypokalemia Alcoholism Drugs • • AZT HMG-CoA reductase inhibitors (the “statins”) Polymyositis/Dermatomyositis [studocu.com]

    IBM inclusion body myositis, NHL non-Hodgkin’s lymphoma Our patient was not receiving any drugs associated with muscle injury, but 5 years after developing non-Hodgkin’s lymphoma, gradual-onset proximal muscle weakness was noted in his legs. [jmedicalcasereports.com]

  • Quadriceps Muscle Weakness

    Rare presentations include sparing of the quadriceps muscles with prominent forearm muscle weakness. Up to 82% of cases have marked asymmetry especially notable in the non-dominant hand deep (distal) finger flexor muscles. [ncbi.nlm.nih.gov]

    Wrist flexor greater than wrist extensor weakness c. Quadriceps muscle weakness (equal to or less than MRC grade 4) B. Laboratory features Serum creatine kinase < 12 times normal Muscle biopsy a. [s-ibm.org]

    Perhaps, subjects investigated in their study comprised more patients with onset with quadriceps muscle weakness, hence progressing earlier to the use of a walking device. [doi.org]

Neurologic

  • Paresis

    Most of the cases presented with paresis predominantly proximal in lower limbs and distal in upper limbs. Immunosuppressive treatment showed to be not effective. [ncbi.nlm.nih.gov]

    Inclusion body myositis presenting with isolated erector spinae paresis. Neurology. 1995 May. 45(5):993-4. [Medline]. Kraemer P, Sagui E, Brosset C, et al. [Inclusion myositis associated with primary biliary cirrhosis of the liver]. [emedicine.medscape.com]

  • Asthenia

    She was exercising daily to increase muscle strength, despite an increased asthenia and difficulties in climbing and descending stairs, and she had some problems in swallowing. [karger.com]

  • Hyperactivity

    Tendon reflexes were considered hyperactive in 2 (patients 3 and 8), normal in weak limbs in 6, and absent in 1. All 9 patients were negative for Hoffmann and Babinski signs. [jamanetwork.com]

Workup

Apart from the physical examination and findings mentioned above, a haemogram would reveal nothing that is diagnostic in value.

Serum Alkaline Phosphatase levels will be significantly raised.
Serum creatine kinase will be low – as low as 12 times below normal.

EMG studies – electromyography would show all the known features of myopathy – inflammatory or non-inflammatory based on the type of Inclusion Body Myositis or Inclusion Body Myopathy.

A muscle biopsy would follow an electromyography to confirm the diagnosis and look for the ‘bodies’ – clusters of degenerated cells. Also, visible would be the invasion of mono nuclear cells in the non-necrotic fibres and vacuolated muscle fibres.

Treatment

In terms of treatment, more than what works, one can be sure of what doesn’t. Based on many reports in the past and clinical studies – steroids, methotrexate, azathioprine and cyclophospamide don’t elicit favourable response from the patients. Similarly immunosuppressive and immunomodulatory therapies are also a failure [4].

Some empirical therapies that may cause some relief or palliation to the patients are Coenzyme Q10, carnitine and anti-oxidants, although unfortunately these are not supported by clinical trials.

Follow up criteria for such patients [5] is the assessment of the pace and progression of the degenerative changes and to note the severity of muscle tissue damage via physical examination assessing the muscle power in terms of strength, stamina and any subsequent problems or difficulties in daily routine activities.

Prognosis

The prognosis for Inclusion Body Myositis is bleak but the only bright side is its slow progression and the fact that most of the times it begins after 50. With some luck most patients having the condition are able to walk with assistance while some may find themselves wheelchair ridden. Another aspect is that the disease is limited to the upper extremities or the muscle tissue it affects is not life threatening [3].

Etiology

While the cause for Inclusion Body Myositis or even myopathy is not very clear, what is known is that it is an autoimmune disorder. The body attacks its own muscle tissue and in the process damages it causing degenerative changes, the exact mechanism of which is not very clear at the moment.

Even though it cannot be pinpointed to one cause, it is clear that there exists a genetic involvement. That gene can be either dominant or recessive, probably linked more to males.

Another known cause is the HIV virus, which acts only in patients already suffering from AIDS. There have been known cases of the patients having affected by the Coxsackie B virus as well.

Drug side-effect involvement has not been ruled out in cases of inclusion body myositis. There are a few drugs that are known to be trigger factors but are pending research e.g. caricaine, carbimazole, cimetidine, penicillamine and phenytoin [1].

Epidemiology

Males have found to be suffering from Inclusion Body Myositis 2 times more than women. The onset of symptoms is usually seen after the age of 50 years but sometimes the symptoms manifest after the 3rd decade of life as well. These symptoms are subtle signs of weakness in the muscles, like the atrophy of the muscles of the forearm or thighs. The same muscular weakness may be seen in the wrist or fingers and occasionally, as dysphagia owing to the weakness of the musculature of the oesophagus [2].

Pathophysiology

The pathophysiology of Inclusion Body Myositis involves both inflammatory as well as degenerative characteristics even though it is known to be similar to other myopathies like dermatomyositis and polymyositis. Though the exact pathogenesis is not clearly known, there are 3 main theories regarding it. One of which is that since it is an auto-immune disorder, there is a primary T-cell mediated response, which is an autoimmune reaction and this causes the muscle damage.

Another theory proposes that the degenerative process is the primary reaction and owing to some protein causes an inflammatory response as the secondary reaction. There is one more theory which claims that both the immune response degenerative changes are two separate reactions and independent of each other which maybe triggered by some external factor.

Prevention

Being a genetically inherited mutation, there is no prevention available for the condition.

Summary

Inclusion Body Myositis (IBM) is the term used to signify a disorder caused due to inflammation of muscles. Its characteristic feature is progressive muscle weakness and wasting. It is a type of myopathy and can affect the blood vessels surrounding the muscles as well. Literal translation will tell us that it means inflammation of the root of the muscle.

One of the characteristics of Inclusion Body Myositis is that the muscle tissue is invaded by a number of inflammatory cells that bring along with it muscle degeneration. Later one can find ‘the bodies’ – that is the waste cells or deceased cells that collect in the tissues of the muscles.

Some rare forms of Inclusion Body Myositis which are genetic or hereditary in nature can present the same symptoms as regular IBM except for the inflammation. In such cases, since there is no inflammation the suffix ‘itis’ is not used and the nomenclature changes to myopathy – inclusion body myopathy – to signify the muscle disorder without the inflammation.

Patient Information

Inclusion Body Myositis is generally a hereditary disorder passed on more in men than women and is usually noticed only after 50 years of age. It is a disease which involves the muscle tissue but is specific only to the muscles of the wrists, upper extremities or of the legs, especially of the thighs. Occasionally it may also involve the muscle of the oesophagus.

As a result of this the symptoms noticed by you may involve dropping things, loosing grip, difficulty in holding objects or if your lower limbs are affected then tripping, falling, loss of footing, difficulty in raising your leg or getting up from a seated position.

Sometimes it may also be caused as a reaction to viruses like the HIV and Coxsackie B. It is essentially an auto-immune disorder, which means, the body cells attack their own muscle tissue. The cause of this is not well understood as is the treatment – another hazy area.

Medicines like CoQ10, carnitine and anti-oxidants may provide some relief. Good news, in a way, is that it is not fatal and has a very slow pace of progression and limits itself to these few areas, not affecting the heart or lungs like other myopathies.

References

  1. Karpati G, O'Ferrall EK. Sporadic inclusion body myositis: pathogenic considerations. Ann Neurol. Jan 2009;65(1):7-11
  2. Cox FM, Titulaer MJ, Sont JK, Wintzen AR, et al. A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities. Brain. Nov 2011;134:3167-75
  3. Lotz BP, Engel AG, Nishino H, et al. Inclusion body myositis. Observations in 40 patients. Brain. Jun 1989;112 (Pt 3):727-47
  4. Breithaupt M, Schmidt J. Update on treatment of inclusion body myositis. Curr Rheumatol Rep. May 2013;15(5):329.
  5. Hicks J. Comprehensive rehabilitative management of patients with polymyositis and dermatomyositis. In: Dalakas M, ed. Polymyositis and Dermatomyositis. Boston, Mass: Butterworth-Heinemann; 1988:293-318.
Languages
Suggested Languages
English en
Other languages 0
2.1
About Symptoma.com COVID-19 Jobs Press Scholarship
Contact Terms Privacy Imprint Medical Device